Skip to main content

Aurora Cannabis Inc(ACB-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Aurora Cannabis Inc up on Friday (ACB)

Automated Summaries - The Globe and Mail - Fri Apr 26, 4:02PM CDT

In market activity today, shares of Aurora Cannabis Inc opened at $9.39 and closed at $9.19. Intraday prices ranged from a low of $9.13 to a high of $10.36.

Share prices raised 0.33 percent from the previous day's close of $9.16.

Today across North America, the TSX Composite closed 0.38% at 21969.24, the S&P 500 closed -0.46% at 5048.42, the Dow Jones Industrial Average closed -0.98% at 38085.80 and the Nasdaq Composite closed -0.64% at 15611.76.

Aurora Cannabis Inc traded under ACB on the Toronto Stock Exchange (TSX).

A total of 4,274,899 shares was traded during the session, with total trades of 18,630. On average, Aurora Cannabis Inc has traded 2,512,663 shares over the last 5-days and 1,346,666 year-to-date.

Trading across the entire TSX saw 3,324 price advancers against 1,856 declines and 124 unchanged.

During the prior 52 weeks, ACB.TO has traded as high as $15.50 (September 12,2023) and low as $3.84 (March 14,2024). Moreover, in the last 12 months, Aurora Cannabis Inc's shares have advanced 19.35%, while they have boosted 41.38% since the start of 2024.

Following today's trading, Aurora Cannabis Inc has a market capitalization of $499.58 million on a float of 54,539 shares outstanding. Its annual EPS is $-79.20.

Aurora Cannabis Inc is a TSX Drug Specialty & Generic company headquartered in Leduc, CAN.

Aurora Cannabis Inc is holding an average recommendation of "Hold" from 6.00 analysts according to Zacks. From those 6 analysts, 1 have buy ratings and 5 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe